Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
13,083 total articles
Fusemachines Inc., a NASDAQ-listed provider of enterprise AI products and services, has appointed Dr. Julia Hirschberg, a distinguished AI researcher and educator, to its Board of Directors. Dr. Hirschberg brings extensive expertise in natural language processing, speech technology, and AI governance, enhancing Fusemachines' commitment to responsib…
Maris-Tech Ltd. has announced the development of Venus-Space, an advanced AI-powered edge video processing platform tailored for low Earth orbit nano satellites. Leveraging upgraded capabilities from its Venus-Pro system, Venus-Space enables ultra-high-resolution video acquisition, onboard AI inference, and real-time streaming, significantly reduci…
ParaZero Technologies Ltd., an aerospace defense company specializing in smart autonomous air systems, announced its first order from a major U.S.-based Tier-1 defense corporation for its DefendAir Net Pods. This order supports integration of ParaZero's non-explosive, net-based Counter-UAS interception technology into advanced autonomous defense ap…
Uniti Group Inc. announced the commencement of a $1.14 billion offering of secured fiber network revenue term notes backed by residential fiber assets across multiple U.S. states. The notes are expected to mature in June 2033, with proceeds intended for general corporate purposes such as capital expenditures and debt repayment. The offering is targ…
Rezolve Ai PLC, trading on NASDAQ as RZLV, reaffirmed its FY26 revenue guidance of approximately $360 million, demonstrating strong confidence backed by accelerating enterprise adoption and conversion of its commercial pipeline. The company reported Q1 2026 revenue of $60 million, surpassing its total 2025 revenue, highlighting significant growth d…
Wave Life Sciences Ltd., a clinical-stage biotechnology company specializing in RNA medicines, announced that its CEO will participate in two major healthcare investor conferences in June 2026. These events provide an opportunity to showcase the company's innovative RNA platform and diverse clinical pipeline targeting various genetic diseases.
Disc Medicine has initiated an expanded access program for its oral GlyT1 inhibitor, bitopertin, allowing eligible U.S. patients with erythropoietic protoporphyria (EPP) early access prior to regulatory approval. Bitopertin is currently in a Phase 3 trial with topline data expected in Q4 2026 and a potential FDA decision anticipated by mid-2027, ai…
Plexus Corp. has released its Fiscal 2025 Sustainability Report, marking a strategic move from intensity-based to absolute emission reduction targets. The company commits to reducing emissions by 2033, has doubled its zero waste sites, enhanced social impact contributions, and improved team member well-being programs, underscoring its dedication to…
IN8bio announced updated clinical data showing that repeat dosing of DeltEx DRI, a gamma-delta T cell therapy, combined with standard-of-care treatment significantly improved median progression-free and overall survival in newly diagnosed glioblastoma patients. Median overall survival exceeded 19.5 months, roughly 48% longer than with standard care…
PolyPid Ltd. has completed the New Drug Application submission to the FDA for D-PLEX100, its lead product candidate aimed at preventing surgical site infections in colorectal surgery patients. The submission follows positive Phase 3 trial results showing a 60% reduction in infection risk and the drug currently holds multiple FDA designations includ…
Jet.AI Inc., a NASDAQ-listed company that provides high-performance GPU infrastructure and AI cloud services, announced that leading proxy advisory firm Glass Lewis recommends stockholders vote in favor of the company's proposed merger with flyExclusive. The Jet.AI Board supports this recommendation and urges stockholders to vote promptly to comple…
Fast Track Group, a Nasdaq-listed entertainment and event management company, announced a multi-part celebrity partnership with Dream Cruises to celebrate its 10th anniversary. The campaign includes exclusive appearances by Chef Tommie Lee onboard the Genting Dream cruise, and upcoming wellness and entertainment components featuring South Korean fi…
T3 Defense Inc., a NASDAQ-listed defense company specializing in acquiring and operating mission-critical defense businesses, announced its participation in the Noble Capital Markets Virtual Equity Conference on June 3-4, 2026. CEO Menny Shalom will engage with investors during the event, with a main presentation scheduled for June 4. The company f…
Rocky Mountain Chocolate Factory announced its fiscal fourth quarter and full year 2026 financial results, highlighting significant operational changes that led to improved product margins but lower overall revenue. The company continues to focus on operational efficiencies, enhancing data analytics, and franchise development despite reporting a ne…
reAlpha Tech Corp., an AI-driven real estate technology company listed on NASDAQ under ticker AIRE, will host a live X Spaces fireside chat featuring its CEO and CFO alongside a Benchmark analyst. The discussion will focus on housing market conditions, mortgage industry trends, AI applications in real estate, and reAlpha's strategic positioning.
National Healthcare Properties, Inc. reported significant growth in its SHOP acquisitions pipeline valued at approximately $279 million, expected to add over 1,200 units to its senior housing portfolio. Additionally, the company's Class A common stock will be included in the Russell 2000 and 3000 Indexes, reflecting its expanding market presence af…
INNOVATE Corp. announced the successful closing of a $105 million refinancing transaction for its broadcasting subsidiary HC2 Broadcasting Holdings Inc. Concurrently, INNOVATE entered into a definitive agreement to sell a 75% controlling interest in Broadcasting to CONX CORP, retaining 25% ownership. The transaction, subject to customary regulatory…
Fate Therapeutics showcased early Phase 1 clinical data for its off-the-shelf CAR T-cell therapy FT836 at the ASCO Annual Meeting, highlighting meaningful tumor reductions in KRAS wild-type metastatic colorectal cancer patients without the need for conditioning chemotherapy. The therapy utilizes novel Sword and Shield technology, enabling persisten…
IperionX Limited announced that titanium fasteners produced with its patented technologies performed substantially better than high-strength SAE Grade 8 steel fasteners in independent tests conducted by the U.S. Army DEVCOM Ground Vehicle Systems Center and Westmoreland Mechanical Testing & Research. The titanium fasteners demonstrated superior tor…
Mixed Martial Arts Group Limited (NYSE American: MMA), operating as MMA.INC, announced that Conor McGregor's return to UFC competition on July 11, 2026 has triggered unprecedented ticket demand and global fan engagement. As McGregor serves as both investor and strategic advisor, the company aims to capitalize on the heightened attention through its…
Celcuity Inc., a clinical-stage biotech company, announced a conference call on June 2, 2026, to discuss results from the PIK3CA mutant cohort of its Phase 3 VIKTORIA-1 clinical trial. This trial evaluates Gedatolisib, a novel PI3K/mTOR inhibitor, in combination regimens for treating hormone receptor positive, HER2-negative advanced breast cancer. …
Cosmos Health Inc. (NASDAQ:COSM) announced its entry into the global animal health sector by launching a veterinary formulation of its antimicrobial product C-Scrub Wash 4%. The product has passed stringent European veterinary disinfectant standards (EN 1656 and EN 1657) and is set to launch first in the UK, with plans for international expansion. …
Jiuzi Holdings announced significant progress in developing its AI intelligent imaging and data platform, moving forward with plans for commercial deployment. The platform integrates AI recognition, data processing, and cloud architecture to provide scalable, real-time analytics solutions designed for enterprise clients. Key features include facial…
Greenwich LifeSciences reports promising open-label data from their Phase III FLAMINGO-01 clinical trial evaluating GLSI-100, an immunotherapy designed to prevent breast cancer recurrences. Preliminary results show a statistically significant increase in injection site immune reactions after multiple vaccinations in a non-HLA-A*02 patient arm, supp…
Osisko Development Corp. has completed a US$300 million offering of 4.125% convertible senior notes due 2031, including the full exercise of initial purchaser options and a private placement with Double Zero Capital. The proceeds, net of costs for capped call transactions to mitigate dilution, will fund the development and pre-construction activiti…
